Skip to main content
Figure 1 | Journal of Hematology & Oncology

Figure 1

From: Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: results of a prospective study (ALL MRD2002 Study)

Figure 1

Impact of post-induction minimal residual disease (MRD) status on overall survival (OS) and disease-free survival (DFS). Patients who were MRD negative after induction therapy (first course A) (n = 26) had a significantly better 3-year DFS compared with those who were MRD positive (n = 13) (69% vs. 31%, p = 0.004).

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us